Joel W. Hay : Citation Profile


Are you Joel W. Hay?

University of Southern California

5

H index

3

i10 index

119

Citations

RESEARCH PRODUCTION:

17

Articles

2

Papers

RESEARCH ACTIVITY:

   38 years (1977 - 2015). See details.
   Cites by year: 3
   Journals where Joel W. Hay has often published
   Relations with other researchers
   Recent citing documents: 1.    Total self citations: 0 (0 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pha1071
   Updated: 2024-01-16    RAS profile: 2023-03-16    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Joel W. Hay.

Is cited by:

Vance, Colin (9)

Frondel, Manuel (6)

Mullahy, John (5)

Davezies, Laurent (4)

Debrand, Thierry (4)

Schmid, Christian (3)

Staub, Kevin (3)

Leung, Siu (2)

Madden, David (2)

Galama, Titus (2)

Puhani, Patrick (2)

Cites to:

Stillman, Steven (5)

Schaffer, Mark (5)

Baum, Christopher (5)

URZUA, SERGIO (3)

Heckman, James (3)

Hausman, Jerry (2)

Stock, James (2)

Hall, Alastair (2)

Arellano, Manuel (2)

Vytlacil, Edward (2)

Kuersteiner, Guido (1)

Main data


Where Joel W. Hay has published?


Journals with more than one article published# docs
PharmacoEconomics3
American Journal of Public Health3
Journal of Business & Economic Statistics2

Recent works citing Joel W. Hay (2024 and 2023)


YearTitle of citing document
2023Physicians Treating Physicians: Relational and Informational Advantages in Treatment and Survival. (2023). Lin, Tzu-Hsin ; Chuang, Hongwei ; Chen, Jennjou. In: IZA Discussion Papers. RePEc:iza:izadps:dp16048.

Full description at Econpapers || Download paper

Works by Joel W. Hay:


YearTitleTypeCited
1987The economic costs of Alzheimers disease In: American Journal of Public Health.
[Citation analysis]
article3
1991Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease In: American Journal of Public Health.
[Citation analysis]
article0
1994The US economic and social costs of Alzheimers disease revisited In: American Journal of Public Health.
[Citation analysis]
article3
1984Let Them Eat Cake: A Note on Comparing Alternative Models of the Demand for Medical Care. In: Journal of Business & Economic Statistics.
[Citation analysis]
article42
1987Ordinary Least Squares and Sample-Selection Models of Health-Care Demand. In: Journal of Business & Economic Statistics.
[Citation analysis]
article25
1994A Procedure for Estimating the Unconditional Cumulative Incidence Curve and its Variability for the Human Immunodeficiency Virus In: Journal of the Royal Statistical Society Series C.
[Full Text][Citation analysis]
article1
1989Econometric issues in modeling the costs of AIDS In: Health Policy.
[Full Text][Citation analysis]
article2
1982Physician-induced demand : An empirical analysis of the consumer information gap In: Journal of Health Economics.
[Full Text][Citation analysis]
article21
1982The demand for dental health In: Social Science & Medicine.
[Full Text][Citation analysis]
article7
Where Do I Send Thee? Does Physician-Ownership Affect Referral Patterns to Ambulatory Surgery Centers In: Mathematica Policy Research Reports.
[Full Text][Citation analysis]
paper4
1977Educational Screening and Occupational Earnings In: NBER Working Papers.
[Full Text][Citation analysis]
paper0
2001Embedding Health-Promoting Changes Into the Daily Lives of Independent-Living Older Adults In: Journals of Gerontology: Series B.
[Full Text][Citation analysis]
article2
2013Cost-Effectiveness Analysis of the Bivalent and Quadrivalent Human Papillomavirus Vaccines from a Societal Perspective in Colombia In: PLOS ONE.
[Full Text][Citation analysis]
article1
2006Cost Effectiveness of Tumour Necrosis Factor-? Inhibitors as First-Line Agents in Rheumatoid Arthritis In: PharmacoEconomics.
[Full Text][Citation analysis]
article5
2013Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2014A Review of the Economic Burden of Glioblastoma and the Cost Effectiveness of Pharmacologic Treatments In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2015A Special Commemorative Issue Honoring William S. Comanor and 50 Years of Pharmaceutical Economics In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
article0
1985Fee-Screen Reimbursement and Physician Fee Inflation In: Journal of Human Resources.
[Full Text][Citation analysis]
article1
2013INCREMENTAL EXPENDITURE OF BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC TREATMENT USING INSTRUMENTAL VARIABLES IN PANEL DATA In: Health Economics.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated December, 10 2023. Contact: CitEc Team